C9466 – Injection, benralizumab, 1 mg
HCPCS Level II code · C codes: Outpatient PPS (Hospital Outpatient)
HCPCS codeC9466
- Long description
- Injection, benralizumab, 1 mg
- Short description
- Injection, benralizumab
- Pricing indicator
53Statute- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Cross reference
- J0517
- Added
- April 1, 2018
- Last change
- January 1, 2019 – No change
- Termination date
- December 31, 2018
Frequently asked questions
What is HCPCS code C9466?
C9466 is a HCPCS Level II code for injection, benralizumab, 1 mg. It was discontinued on December 31, 2018.
Does Medicare cover C9466?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby C codes
- C9458 – Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
- C9459 – Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
- C9460 – Injection, cangrelor, 1 mg
- C9461 – Choline c 11, diagnostic, per study dose
- C9462 – Injection, delafloxacin, 1 mg
- C9463 – Injection, aprepitant, 1 mg
- C9464 – Injection, rolapitant, 0.5 mg
- C9465 – Hyaluronan or derivative, durolane, for intra-articular injection, per dose
- C9467 – Injection, rituximab and hyaluronidase, 10 mg
- C9468 – Injection, factor ix (antihemophilic factor, recombinant), glycopegylated, rebinyn, 1 i.u.
- C9469 – Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
- C9470 – Injection, aripiprazole lauroxil, 1 mg
- C9471 – Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg
- C9472 – Injection, talimogene laherparepvec, 1 million plaque forming units (pfu)
- C9473 – Injection, mepolizumab, 1 mg
- C9474 – Injection, irinotecan liposome, 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.